Cognitive Decline in Preclinical Stage 2 Alzheimer Disease and Implications for Prevention Trials

JAMA Neurol. 2016 Jun 1;73(6):640-2. doi: 10.1001/jamaneurol.2016.0281.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Alzheimer Disease*
  • Cognitive Dysfunction*
  • Disease Progression
  • Humans
  • Neuropsychological Tests